Skin Allergy Therapeutics Market by Indication (Angioedema, Contact Dermatitis, Eczema), Route of Administration (Oral, Parenteral), Treatment, Distribution Channel - Global Forecast 2024-2030

Skin Allergy Therapeutics Market by Indication (Angioedema, Contact Dermatitis, Eczema), Route of Administration (Oral, Parenteral), Treatment, Distribution Channel - Global Forecast 2024-2030


The Skin Allergy Therapeutics Market size was estimated at USD 5.04 billion in 2023 and expected to reach USD 5.43 billion in 2024, at a CAGR 8.15% to reach USD 8.73 billion by 2030.

Global Skin Allergy Therapeutics Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Skin Allergy Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Skin Allergy Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Skin Allergy Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Astellas Pharma International B.V., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, DBV Technologies Inc., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., HYCOR Biomedical, LLC, Johnson & Johnson Consumer Inc., LEO Pharma A/S, Ligand Pharmaceuticals Incorporated, Lincoln Diagnostics, Inc., Merck KGaA, Omega Diagnostics Group PLC, Pfizer Inc., Piramal Enterprises Limited, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Synnat Pharma Private Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage



This research report categorizes the Skin Allergy Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
Angioedema
Contact Dermatitis
Eczema
Urticaria
Route of Administration
Oral
Parenteral
Treatment
Immunotherapy
Oral Medications
Phototherapy
Topical Treatments
Distribution Channel
Offline
Drug Stores
Retail Pharmacies
Online
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Skin Allergy Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Skin Allergy Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Skin Allergy Therapeutics Market?
4. What is the market share of the leading vendors in the Skin Allergy Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Skin Allergy Therapeutics Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Skin Allergy Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of skin allergy conditions among population
5.1.1.2. Growing awareness of skincare and detection of skin allergies
5.1.2. Restraints
5.1.2.1. High costs associated with skincare treatments
5.1.3. Opportunities
5.1.3.1. Robust research activities to develop novel skin allergy therapeutics
5.1.3.2. Improved healthcare infrastructure and medical spendings
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for therapeutics development
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Skin Allergy Therapeutics Market, by Indication
6.1. Introduction
6.2. Angioedema
6.3. Contact Dermatitis
6.4. Eczema
6.5. Urticaria
7. Skin Allergy Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
8. Skin Allergy Therapeutics Market, by Treatment
8.1. Introduction
8.2. Immunotherapy
8.3. Oral Medications
8.4. Phototherapy
8.5. Topical Treatments
9. Skin Allergy Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3.1. Drug Stores
9.3.2. Retail Pharmacies
9.3. Online
10. Americas Skin Allergy Therapeutics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Skin Allergy Therapeutics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Skin Allergy Therapeutics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ALK-Abelló A/S
14.1.2. Astellas Pharma International B.V.
14.1.3. AstraZeneca PLC
14.1.4. Bausch Health Companies Inc
14.1.5. Bayer AG
14.1.6. DBV Technologies Inc.
14.1.7. Dr.Reddy's Laboratories Limited
14.1.8. Eisai Co., Ltd.
14.1.9. Eli Lilly and Company
14.1.10. GlaxoSmithKline PLC
14.1.11. Glenmark Pharmaceuticals Ltd.
14.1.12. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
14.1.13. HYCOR Biomedical, LLC
14.1.14. Johnson & Johnson Consumer Inc.
14.1.15. LEO Pharma A/S
14.1.16. Ligand Pharmaceuticals Incorporated
14.1.17. Lincoln Diagnostics, Inc.
14.1.18. Merck KGaA
14.1.19. Omega Diagnostics Group PLC
14.1.20. Pfizer Inc.
14.1.21. Piramal Enterprises Limited
14.1.22. Sanofi S.A.
14.1.23. Sun Pharmaceutical Industries Ltd.
14.1.24. Synnat Pharma Private Limited
14.1.25. Teva Pharmaceutical Industries Ltd.
14.1.26. Viatris Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. SKIN ALLERGY THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SKIN ALLERGY THERAPEUTICS MARKET DYNAMICS
FIGURE 7. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 12. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings